HDM2 Inhibitor JNJ-26854165
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Antineoplastic Agent -> HDM2 Inhibitor JNJ-26854165
HDM2 Inhibitor JNJ-26854165 Definition
An orally bioavailable HDM2 antagonist with potential antineoplastic activity. Hdm2 inhibitor JNJ-26854165 inhibits the binding of the HDM2 protein to the transcriptional activation domain of the tumor suppressor protein p53. By preventing this HDM2-p53 interaction, the proteosome-mediated enzymatic degradation of p53 is inhibited, which may result in the restoration of p53 signaling and thus the p53-mediated induction of tumor cell apoptosis. HDM2 (human homolog of double minute 2), a zinc finger protein, is a negative regulator of the p53 pathway; often overexpressed in cancer cells, it has been implicated in cancer cell proliferation and survival.
HDM2 Inhibitor JNJ-26854165 Synonyms
HDM2 Inhibitor JNJ-26854165, JNJ-26854165
Terms in HDM2 Inhibitor JNJ-26854165 category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.